drugset / Trial / NCT00833807

Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver

NCT00833807 ↗

NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research is to find the highest tolerable dose of Abraxane (nab-paclitaxel) when given directly to the area where the cancer is located. The safety of this drug will also be studied.

Timeline

Start
2009-02
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nab-paclitaxel Small molecule 130 mg/m2 Other

Indications